GenSight Biologics Reports Evidence of GS010 DNA Transfer to Contralateral Eye of Primates Unilaterally Injected With GS010 Gene Therapy

First study to find direct evidence that therapeutic gene is transferred from the injected eye to the uninjected contralateral eye of primates Findings support mechanism for bilateral visual improvement with unilateral GS010 gene therapy, which was consistently observed in LHON subjects in the REVERSE and RESCUE Phase III trials PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: … [Read more…]

Novigenix Receives Reimbursement Coverage for Colox® in Switzerland

First liquid biopsy test reimbursed in Switzerland for colon cancer screening through private outpatient supplementary insurance product offered by Helsana LAUSANNE, Switzerland–(BUSINESS WIRE)–Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and precision medicine. today announced that Helsana, the leading health insurance provider in Switzerland, has started coverage for … [Read more…]

Jorveza®: Innovation through ingenious galenics

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, which can be effectively treated with topical steroids. Yet until recently, no mode of administration had been approved and optimised specifically for EoE. This gap has now been closed by the new budesonide orodispersible tablet (with effervescent quality) Jorveza®, which gastroenterologists considered the … [Read more…]